NASDAQ:ARDS - Aridis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$9.60 -1.15 (-10.70 %)
(As of 12/17/2018 06:00 AM ET)
Previous Close$9.60
Today's Range$8.66 - $10.75
52-Week Range$7.59 - $13.85
Volume2,277 shs
Average Volume6,883 shs
Market Capitalization$77.81 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Aridis Pharmaceuticals (NASDAQ:ARDS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Aridis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $28.25, suggesting that the stock has a possible upside of 194.27%. The high price target for ARDS is $40.00 and the low price target for ARDS is $23.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $28.25$28.25$29.3333N/A
Price Target Upside: 194.27% upside132.51% upside136.79% upsideN/A

Aridis Pharmaceuticals (NASDAQ:ARDS) Consensus Price Target History

Price Target History for Aridis Pharmaceuticals (NASDAQ:ARDS)

Aridis Pharmaceuticals (NASDAQ:ARDS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2018Maxim GroupSet Price TargetBuy$25.00LowView Rating Details
11/13/2018Cantor FitzgeraldReiterated RatingBuy$25.00LowView Rating Details
9/10/2018Northcoast ResearchInitiated CoverageOutperform$40.00LowView Rating Details
9/10/2018Northland SecuritiesInitiated CoverageOutperformLowView Rating Details
9/10/2018LaidlawInitiated CoverageBuy$23.00LowView Rating Details
(Data available from 12/17/2016 forward)
This page was last updated on 12/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel